Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura

Status Completed

Clinical Trial Summary

Acupuncture is commonly used for the prevention of migraine, while the evidence for its efficacy is still uncertain. Current studies have not been able to determine whether the efficacy of acupuncture is due to the actual therapeutic effect of acupuncture, or a result of psychological benefits. To address this issue, we designed a clinical trial to evaluate the prophylactic efficacy of acupuncture for migraine without aura (MWoA). Furthermore, we will evaluate the impact of Chinese medicine factors and psychological factors on the efficacy of acupuncture.

Clinical Trial Description

This is a multicentre, stratified, randomized, sham-controlled clinical trial. 150 eligible participants will be randomly allocated into verum acupuncture, sham acupuncture, or usual care groups, in a 2:2:1 ratio. The verum acupuncture group will receive twenty verum acupuncture treatments over an eight-week period, while the sham acupuncture group will receive sham acupuncture treatments with non-penetrating needling. Participants assigned to the usual care group are scheduled to receive twenty verum acupuncture treatments for free after waiting 24 weeks. Health education will be provided to participants in the three groups. The primary outcomes will be the changes in the mean number of migraine days and migraine attacks per four-week cycle. The secondary outcomes will be as follows: the proportion of responders, migraine intensity, migraine disability assessment questionnaire, health-related and sleep-related quality of life, the dose of intake of acute medication. Chinese medicine factors will include de qi sensations and Traditional Chinese Medicine (TCM) constitution. Psychological outcomes will include anxiety, depression, personality, expectancy about acupuncture, and doctor-patient relationship. The central randomization and data collection will be conducted by an electronic data management system. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02765581
Study type	Interventional
Source	Huazhong University of Science and Technology
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2016
Completion date	November 20, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02202486` - Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI	N/A
Completed	`NCT01687660` - Acupuncture for Migraine Prophylaxis	N/A
Completed	`NCT00363532` - Functional MRI (fMRI) in CGRP Induced Migraine	N/A
Completed	`NCT00123201` - Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache	Phase 2
Completed	`NCT04406649` - A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine	Phase 3
Completed	`NCT03874832` - A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects	Phase 1
Recruiting	`NCT05565001` - The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.	N/A
Completed	`NCT04533568` - Ibuprofen in Migraine Patients	Phase 4
Recruiting	`NCT06459635` - Migraine Attack Pain Phase Prediction Study
Recruiting	`NCT05416476` - Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine	Phase 3
Completed	`NCT04636359` - Study the Effect of Acupuncture on Migraine Patient Without Aura Via Functional Magnetic Resonance Imaging.	N/A
Completed	`NCT00534560` - Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache	Phase 2
Terminated	`NCT04936061` - Transnasal Cooling for Migraine	N/A
Recruiting	`NCT05281770` - Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Completed	`NCT00380263` - PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow	N/A
Completed	`NCT00334178` - Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine	Phase 3
Recruiting	`NCT06051604` - Mi-Helper Transnasal Cooling for Acute Treatment of Migraine	N/A
Recruiting	`NCT06414044` - Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Completed	`NCT03472378` - Can DFN-15 Terminate Migraine With Allodynia?	Phase 2
Recruiting	`NCT05211154` - Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine	Phase 4